Cover
Cover | Apr. 10, 2024 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 10, 2024 |
Entity File Number | 001-40608 |
Entity Registrant Name | Estrella Immunopharma, Inc. |
Entity Central Index Key | 0001844417 |
Entity Tax Identification Number | 86-1314502 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 5858 Horton Street |
Entity Address, Address Line Two | Suite 370 |
Entity Address, City or Town | Emeryville |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94608 |
City Area Code | 510 |
Local Phone Number | 318-9098 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Common Stock Par Value 0. 0001 Per Share [Member] | |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | ESLA |
Security Exchange Name | NASDAQ |
Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At Exercise Price Of 11. 50 [Member] | |
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 |
Trading Symbol | ESLAW |
Security Exchange Name | NASDAQ |